News

Upon issuance, the U.S. Patent entitled, "Process for Producing a Composition Containing Active Follistatin," will provide intellectual property protection for making the key ingredient in MYOS’ core commercial

Abbott (ABT), the makers of Similac and experts in infant nutrition for nearly 90 years, studied the diets of more than 80 lactating women to assess how their

Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States. With this addition, WCG’s biosafety division

Zydelig has been approved by The U.S. Food and Drug Administration (FDA) for the treatment of three different B-cell blood cancers: 1. In combination with rituximab for patients

KX2-391 is a synthetic, orally active and highly selective inhibitor of Src tyrosine kinase signaling and tubulin polymerization. KX2-391 promotes the induction of p53, G2/M arrest of proliferating

The filing of the application will follow the Article 58 procedure, which enables the EMA to evaluate the quality, safety and efficacy of a candidate vaccine, or medicine,

Malignant hyperthermia is an inherited and potentially fatal disorder triggered by certain anesthesia agents in genetically susceptible individuals. The FDA had granted orphan drug designated to Ryanodex in

The new product, which will be launched after Health Canada approval, uses a patented delivery system that provides technical advantages over existing alternatives and will be used in

NPC is a rare disease seen mostly of children who are afflicted with Alzheimer-like symptoms. According to the company, the licence also covers other diseases and disorders relying